
Altavo concludes Series A2 for the development of its Artificial Voice
Altavo GmbH, a medical technology startup for AI-based voice rehabilitation, has closed a Series A2 financing round. A European consortium led by Novalis Biotech and bm|t is investing € 3 million in the development of Altavo’s innovative artificial voice.